Review




Structured Review

CSL Behring csl-111
Csl 111, supplied by CSL Behring, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/csl-111/csl+111/bio_rxiv__2025__07__09__663869-19-12-8
Average 90 stars, based on 1 article reviews
csl-111 - by Bioz Stars, 2026-09
90/100 stars

Images

Related Articles

Isolation:

Article Title: HDL and pancreatic β cells: a SMO-king gun?
Article Snippet: CSL-111, was kindly provided by CSL Behring (King of Prussia, PA).

Article Title: Investigating the Effect of a Single Infusion of Reconstituted High-Density Lipoprotein in Patients with Symptomatic Carotid Plaques
Article Snippet: Consequently, the drug manufacturers (CSL-Behring) are currently designing a new variant of CSL-111 (product used in this trial), which is potentially more antiatherogenic with greater cholesterol efflux capacity, without the hepatotoxic properties of CSL-111.

Article Title: HDL inhibits endoplasmic reticulum stress-induced apoptosis of pancreatic β-cells in vitro by activation of Smoothened
Article Snippet: CSL-111, was kindly provided by CSL Behring (King of Prussia, Pennsylvania, United States).

Article Title: High-Density Lipoproteins (HDL) – Nature’s Multi-Functional Nanoparticles
Article Snippet: 20 , 21 Following ZLB acquisition by CSL Behring, Australia in 2000, SRC-rHDL was renamed as CSL-111.

Article Title: Aerosolized ApoA1 Nanoparticles Synthesized by Microfluidics Cross the Lung Barrier and Modulate Inflammation
Article Snippet: To reduce the cholesterol burden in atherosclerotic plaques, CSL Behring has developed CSL-111 and CSL-112 formulations, composed of phospholipids and ApoA1 isolated from human plasma.

Article Title: List of drugs in development for neurodegenerative diseases: update October 2011.
Article Snippet: *No development reported (Discovery) CSL Behring CSL-111 Atherosclerosis; Stroke HDL cholesterol enhancer Neuroprotectant 284.

Article Title: HDL and pancreatic β cells: a SMO-king gun?
Article Snippet: We thank Dr. Samuel Wright (CSL Behring, USA) for providing CSL-111.

Article Title: HDL in sepsis – risk factor and therapeutic approach
Article Snippet: CSL-111 is a rHDL originally produced by CSL Behring for the intention of treating atherosclerosis, making it through Phase II Clinical Trial before being superseded by CSL-112, CSL Behring’s current investigational rHDL therapeutic ( ).

Clinical Proteomics:

Article Title: HDL and pancreatic β cells: a SMO-king gun?
Article Snippet: CSL-111, was kindly provided by CSL Behring (King of Prussia, PA).

Article Title: Investigating the Effect of a Single Infusion of Reconstituted High-Density Lipoprotein in Patients with Symptomatic Carotid Plaques
Article Snippet: Consequently, the drug manufacturers (CSL-Behring) are currently designing a new variant of CSL-111 (product used in this trial), which is potentially more antiatherogenic with greater cholesterol efflux capacity, without the hepatotoxic properties of CSL-111.

Article Title: HDL inhibits endoplasmic reticulum stress-induced apoptosis of pancreatic β-cells in vitro by activation of Smoothened
Article Snippet: CSL-111, was kindly provided by CSL Behring (King of Prussia, Pennsylvania, United States).

Article Title: High-Density Lipoproteins (HDL) – Nature’s Multi-Functional Nanoparticles
Article Snippet: 20 , 21 Following ZLB acquisition by CSL Behring, Australia in 2000, SRC-rHDL was renamed as CSL-111.

Article Title: Aerosolized ApoA1 Nanoparticles Synthesized by Microfluidics Cross the Lung Barrier and Modulate Inflammation
Article Snippet: To reduce the cholesterol burden in atherosclerotic plaques, CSL Behring has developed CSL-111 and CSL-112 formulations, composed of phospholipids and ApoA1 isolated from human plasma.

Article Title: List of drugs in development for neurodegenerative diseases: update October 2011.
Article Snippet: *No development reported (Discovery) CSL Behring CSL-111 Atherosclerosis; Stroke HDL cholesterol enhancer Neuroprotectant 284.

Article Title: HDL and pancreatic β cells: a SMO-king gun?
Article Snippet: We thank Dr. Samuel Wright (CSL Behring, USA) for providing CSL-111.

Article Title: HDL in sepsis – risk factor and therapeutic approach
Article Snippet: CSL-111 is a rHDL originally produced by CSL Behring for the intention of treating atherosclerosis, making it through Phase II Clinical Trial before being superseded by CSL-112, CSL Behring’s current investigational rHDL therapeutic ( ).

Cell Culture:

Article Title: HDL and pancreatic β cells: a SMO-king gun?
Article Snippet: CSL-111, was kindly provided by CSL Behring (King of Prussia, PA).

Article Title: Investigating the Effect of a Single Infusion of Reconstituted High-Density Lipoprotein in Patients with Symptomatic Carotid Plaques
Article Snippet: Consequently, the drug manufacturers (CSL-Behring) are currently designing a new variant of CSL-111 (product used in this trial), which is potentially more antiatherogenic with greater cholesterol efflux capacity, without the hepatotoxic properties of CSL-111.

Article Title: HDL inhibits endoplasmic reticulum stress-induced apoptosis of pancreatic β-cells in vitro by activation of Smoothened
Article Snippet: CSL-111, was kindly provided by CSL Behring (King of Prussia, Pennsylvania, United States).

Article Title: High-Density Lipoproteins (HDL) – Nature’s Multi-Functional Nanoparticles
Article Snippet: 20 , 21 Following ZLB acquisition by CSL Behring, Australia in 2000, SRC-rHDL was renamed as CSL-111.

Article Title: Aerosolized ApoA1 Nanoparticles Synthesized by Microfluidics Cross the Lung Barrier and Modulate Inflammation
Article Snippet: To reduce the cholesterol burden in atherosclerotic plaques, CSL Behring has developed CSL-111 and CSL-112 formulations, composed of phospholipids and ApoA1 isolated from human plasma.

Article Title: List of drugs in development for neurodegenerative diseases: update October 2011.
Article Snippet: *No development reported (Discovery) CSL Behring CSL-111 Atherosclerosis; Stroke HDL cholesterol enhancer Neuroprotectant 284.

Article Title: HDL and pancreatic β cells: a SMO-king gun?
Article Snippet: We thank Dr. Samuel Wright (CSL Behring, USA) for providing CSL-111.

Article Title: HDL in sepsis – risk factor and therapeutic approach
Article Snippet: CSL-111 is a rHDL originally produced by CSL Behring for the intention of treating atherosclerosis, making it through Phase II Clinical Trial before being superseded by CSL-112, CSL Behring’s current investigational rHDL therapeutic ( ).

Transfection:

Article Title: HDL and pancreatic β cells: a SMO-king gun?
Article Snippet: CSL-111, was kindly provided by CSL Behring (King of Prussia, PA).

Article Title: Investigating the Effect of a Single Infusion of Reconstituted High-Density Lipoprotein in Patients with Symptomatic Carotid Plaques
Article Snippet: Consequently, the drug manufacturers (CSL-Behring) are currently designing a new variant of CSL-111 (product used in this trial), which is potentially more antiatherogenic with greater cholesterol efflux capacity, without the hepatotoxic properties of CSL-111.

Article Title: HDL inhibits endoplasmic reticulum stress-induced apoptosis of pancreatic β-cells in vitro by activation of Smoothened
Article Snippet: CSL-111, was kindly provided by CSL Behring (King of Prussia, Pennsylvania, United States).

Article Title: High-Density Lipoproteins (HDL) – Nature’s Multi-Functional Nanoparticles
Article Snippet: 20 , 21 Following ZLB acquisition by CSL Behring, Australia in 2000, SRC-rHDL was renamed as CSL-111.

Article Title: Aerosolized ApoA1 Nanoparticles Synthesized by Microfluidics Cross the Lung Barrier and Modulate Inflammation
Article Snippet: To reduce the cholesterol burden in atherosclerotic plaques, CSL Behring has developed CSL-111 and CSL-112 formulations, composed of phospholipids and ApoA1 isolated from human plasma.

Article Title: List of drugs in development for neurodegenerative diseases: update October 2011.
Article Snippet: *No development reported (Discovery) CSL Behring CSL-111 Atherosclerosis; Stroke HDL cholesterol enhancer Neuroprotectant 284.

Article Title: HDL and pancreatic β cells: a SMO-king gun?
Article Snippet: We thank Dr. Samuel Wright (CSL Behring, USA) for providing CSL-111.

Article Title: HDL in sepsis – risk factor and therapeutic approach
Article Snippet: CSL-111 is a rHDL originally produced by CSL Behring for the intention of treating atherosclerosis, making it through Phase II Clinical Trial before being superseded by CSL-112, CSL Behring’s current investigational rHDL therapeutic ( ).



Similar Products

90
CSL Behring csl-111
Csl 111, supplied by CSL Behring, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/csl-111/csl+111/bio_rxiv__2025__07__09__663869-19-12-8
Average 90 stars, based on 1 article reviews
csl-111 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
CSL Behring hdl-mimetic nanoparticles srcrhdl/csl-111
Hdl Mimetic Nanoparticles Srcrhdl/Csl 111, supplied by CSL Behring, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/csl-111/csl+111/pm33949389-81-12-5
Average 90 stars, based on 1 article reviews
hdl-mimetic nanoparticles srcrhdl/csl-111 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Mimetics recombinant hdl mimetics csl-111
Recombinant Hdl Mimetics Csl 111, supplied by Mimetics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/csl-111/recombinant+hdl+mimetics+csl+111/10__1161_slash_atvbaha__120__314956-189-7-9
Average 90 stars, based on 1 article reviews
recombinant hdl mimetics csl-111 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
CSL Behring rhdl csl-111
Rhdl Csl 111, supplied by CSL Behring, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/csl-111/csl+111/pmc07226336-139-4-7
Average 90 stars, based on 1 article reviews
rhdl csl-111 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
CSL Behring reconstituted hdls csl-111
Reconstituted Hdls Csl 111, supplied by CSL Behring, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/csl-111/csl+111/10__1097_slash_aln__0000000000003155-40-1-6
Average 90 stars, based on 1 article reviews
reconstituted hdls csl-111 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
CSL Behring reconstituted human hdl csl-111
Reconstituted Human Hdl Csl 111, supplied by CSL Behring, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/csl-111/csl+111/10__1194_slash_jlr__m085456-43-4-10
Average 90 stars, based on 1 article reviews
reconstituted human hdl csl-111 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results